Clinical Trial Update: Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating hyperthermic intraperitoneal chemoperfusion (HIPEC) for gastric cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Gastric Neoplasms | Phase 2 | Status: WITHDRAWN